1e
19
1
49
2
2
18
1b
1d
18
35
8c
1d
2 29
1d
25
Stefan K. Barta, MD, MS
88
8c
Associate Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
28
5f
3
5f
Director, T-cell Lymphoma Program, UPenn
11
Department: Medicine
4
1
b
1d
46
Contact information
3d
4
3
3
3
2
29
4
b
1f
3d
Perelman Center
1f 12th Floor, Room 12-177
39 3400 Civic Center Blvd
Philadelphia, PA 19104
26
1f 12th Floor, Room 12-177
39 3400 Civic Center Blvd
Philadelphia, PA 19104
2c
Office: 2156156506
30 Fax: 2156155887
24
f
30 Fax: 2156155887
24
13
Education:
21 7 MD 15 (Medicine) c
3b Johann-Wolfgang Goethe University , 1999.
21 7 MS 26 (Clinical Research Methods) c
3d Albert Einstein College of Medicine , 2011.
c
3
3
3
3
8d
Permanent link21 7 MD 15 (Medicine) c
3b Johann-Wolfgang Goethe University , 1999.
21 7 MS 26 (Clinical Research Methods) c
3d Albert Einstein College of Medicine , 2011.
c
2 29
21
1e
1d
24
5e
71
e 29
27
Description of Clinical Expertise
4f T-cell lymphomas; HIV-associated lymphomas; Cutaneous lymphomas71
Description of Research Expertise
4d HIV related lymphomas; T-cell lymphomas; Cutaneous lymphomas.e 29
23
fe Omar Elghawy, Nishwant Swami, Zachary A. Hing & Stefan K. Barta: Advances in T-cell lymphomas and risk factors for CNS involvement. Leukemia & Lymphoma 66(9): 1583-1602, July 2025.
1e2 Omar Elghawy, Julia Wang, Olivia J. Leung, Nishwant Swami, Veronica Carvajal, Guang Yang, Daniel J. Landsburg, Jakub Svoboda, Sunita D. Nasta, Elise A. Chong, Stephen J. Schuster, Colin J. Thomas, Jordan S. Carter, Adam Bagg, Stefan K. Barta : Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution Experience. Clinical Lymphoma Myeloma and Leukemia 25(7): 505-511, July 2025.
287 Nicole J. Altomare, Megan M. Herr, Nisha M. Nair, Deborah M. Stephens, Jonathon B. Cohen, Narendranath Epperla, Matthew Cortese, Rahul Bhansali, Tamara K. Moyo, Vaishalee Kenkre, Thomas Ollila, Brian Hess, Lindsey Fitzgerald, Geoffrey Shouse, James A. Davis, Christy Jesme, Ari Pelcovits, Jonathan Moreira, Adam Lin, Shuo Ma, Jane N. Winter, Alexey Danilov, Stefan K. Barta, Leo I. Gordon, Jason Romancik, Natalie S. Grover and Reem Karmali: Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART. Cancers 17(14): 2358, July 2025.
1be Danilov AV, Sauter C, Phillips T, Coombs CC, Ip A, Wang Y, Rhodes J, Leslie L, Barrientos J, Saeed H, Strati P, Barta SK, Shadman M.: Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference. Clinical Lymphoma Myeloma and Leukemia 25(6): e366-e373, June 2025.
101 Jordan Carter, Jonathan M von Reusner, Mark A Sellmyer, Adam Bagg, Stefan K Barta: Common Lymphoma in an Uncommon Location. American Journal of Hematology 100(8): 1437-1439, June 2025.
3ea Jakub Svoboda, M.D., Daniel J. Landsburg, M.D., James Gerson, M.D., Sunita D. Nasta, M.D., Stefan K. Barta, M.D., Elise A. Chong, M.D., Michael Cook, M.D., Noelle V. Frey, M.D., Joanne Shea, R.N., Amanda Cervini, B.S.N., Amy Marshall, M.P.H., Megan Four, B.S., Megan M. Davis, Ph.D., Julie K. Jadlowsky, Ph.D., Anne Chew, Ph.D., Edward Pequignot, M.S., Vanessa Gonzalez, M.B.A., Julia Han Noll, M.S., Luca Paruzzo, M.D., Juliana Rojas-Levine, B.S., Gabriela Plesa, M.D., Ph.D., John Scholler, M.S., Donald L. Siegel, M.D., Ph.D., Bruce L. Levine, Ph.D., David L. Porter, M.D., Saba Ghassemi, Ph.D., Marco Ruella, M.D., Andrew Rech, M.D., Ph.D., Rachel M. Leskowitz, Ph.D., Joseph A. Fraietta, Ph.D., Wei-Ting Hwang, Ph.D., Elizabeth Hexner, M.D., Stephen J. Schuster, M.D., and Carl H. June, M.D. : Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure. The New England Journal of Medicine 392(18): 1824-1835, May 2025.
213 Narendranath Epperla, Geoffrey Shouse, Natalie S. Grover, Pallawi Torka, Kaitlin Annunzio, Marcus Watkins, Andrea Anampa-Guzmán, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Reem Karmali, Nancy L. Bartlett & Adam J. Olszewski : Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite study. Experimental Hematology & Oncology 14(73): 73, May 2025.
1cb Maillie L, Nasta SD, Svoboda J, Barta SK, Chong EA, Garfall AL, Gill SI, Porter DL, Schuster SJ, Catania C, Frey NV, Landsburg DJ.: Prolonged Neurologic Symptoms Following Immune Effector Cell-Associated Neurotoxicity Syndrome in Patients With Large B-cell Lymphoma Treated With Chimeric Antigen Receptor-Modified T Cell Therapy. Transplant and Cell Therapy 31(4): 228-235, April 2025.
17d Dave NK, Carvajal V, Watts AC, Carter JS, Cook M, Thomas C, Tsai DE, Schuster SJ, Gerson JN, Barta SK, Svoboda J, Chong EA, Hwang WT, Landsburg DJ, Nasta SD.: Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma. Blood Neoplasia 2: 100102, Apr 2025.
2c
7
1d
1f
Selected Publications
1da Nikita K. Dave, Veronica Carvajal, Alex C. Watts, Jordan S. Carter, Michael Cook, Colin Thomas, Donald E. Tsai, Stephen J. Schuster, James N. Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Wei-Ting Hwang, Daniel J. Landsburg, Sunita D. Nasta : Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma Blood Neoplasia 2(3), August 2025.fe Omar Elghawy, Nishwant Swami, Zachary A. Hing & Stefan K. Barta: Advances in T-cell lymphomas and risk factors for CNS involvement. Leukemia & Lymphoma 66(9): 1583-1602, July 2025.
1e2 Omar Elghawy, Julia Wang, Olivia J. Leung, Nishwant Swami, Veronica Carvajal, Guang Yang, Daniel J. Landsburg, Jakub Svoboda, Sunita D. Nasta, Elise A. Chong, Stephen J. Schuster, Colin J. Thomas, Jordan S. Carter, Adam Bagg, Stefan K. Barta : Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution Experience. Clinical Lymphoma Myeloma and Leukemia 25(7): 505-511, July 2025.
287 Nicole J. Altomare, Megan M. Herr, Nisha M. Nair, Deborah M. Stephens, Jonathon B. Cohen, Narendranath Epperla, Matthew Cortese, Rahul Bhansali, Tamara K. Moyo, Vaishalee Kenkre, Thomas Ollila, Brian Hess, Lindsey Fitzgerald, Geoffrey Shouse, James A. Davis, Christy Jesme, Ari Pelcovits, Jonathan Moreira, Adam Lin, Shuo Ma, Jane N. Winter, Alexey Danilov, Stefan K. Barta, Leo I. Gordon, Jason Romancik, Natalie S. Grover and Reem Karmali: Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART. Cancers 17(14): 2358, July 2025.
1be Danilov AV, Sauter C, Phillips T, Coombs CC, Ip A, Wang Y, Rhodes J, Leslie L, Barrientos J, Saeed H, Strati P, Barta SK, Shadman M.: Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference. Clinical Lymphoma Myeloma and Leukemia 25(6): e366-e373, June 2025.
101 Jordan Carter, Jonathan M von Reusner, Mark A Sellmyer, Adam Bagg, Stefan K Barta: Common Lymphoma in an Uncommon Location. American Journal of Hematology 100(8): 1437-1439, June 2025.
3ea Jakub Svoboda, M.D., Daniel J. Landsburg, M.D., James Gerson, M.D., Sunita D. Nasta, M.D., Stefan K. Barta, M.D., Elise A. Chong, M.D., Michael Cook, M.D., Noelle V. Frey, M.D., Joanne Shea, R.N., Amanda Cervini, B.S.N., Amy Marshall, M.P.H., Megan Four, B.S., Megan M. Davis, Ph.D., Julie K. Jadlowsky, Ph.D., Anne Chew, Ph.D., Edward Pequignot, M.S., Vanessa Gonzalez, M.B.A., Julia Han Noll, M.S., Luca Paruzzo, M.D., Juliana Rojas-Levine, B.S., Gabriela Plesa, M.D., Ph.D., John Scholler, M.S., Donald L. Siegel, M.D., Ph.D., Bruce L. Levine, Ph.D., David L. Porter, M.D., Saba Ghassemi, Ph.D., Marco Ruella, M.D., Andrew Rech, M.D., Ph.D., Rachel M. Leskowitz, Ph.D., Joseph A. Fraietta, Ph.D., Wei-Ting Hwang, Ph.D., Elizabeth Hexner, M.D., Stephen J. Schuster, M.D., and Carl H. June, M.D. : Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure. The New England Journal of Medicine 392(18): 1824-1835, May 2025.
213 Narendranath Epperla, Geoffrey Shouse, Natalie S. Grover, Pallawi Torka, Kaitlin Annunzio, Marcus Watkins, Andrea Anampa-Guzmán, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Reem Karmali, Nancy L. Bartlett & Adam J. Olszewski : Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite study. Experimental Hematology & Oncology 14(73): 73, May 2025.
1cb Maillie L, Nasta SD, Svoboda J, Barta SK, Chong EA, Garfall AL, Gill SI, Porter DL, Schuster SJ, Catania C, Frey NV, Landsburg DJ.: Prolonged Neurologic Symptoms Following Immune Effector Cell-Associated Neurotoxicity Syndrome in Patients With Large B-cell Lymphoma Treated With Chimeric Antigen Receptor-Modified T Cell Therapy. Transplant and Cell Therapy 31(4): 228-235, April 2025.
17d Dave NK, Carvajal V, Watts AC, Carter JS, Cook M, Thomas C, Tsai DE, Schuster SJ, Gerson JN, Barta SK, Svoboda J, Chong EA, Hwang WT, Landsburg DJ, Nasta SD.: Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma. Blood Neoplasia 2: 100102, Apr 2025.
2c